Skip to Content
Merck
All Photos(1)

Documents

219878

Sigma-Aldrich

4-Hydroxyindole

99%

Synonym(s):

4-Indolol, 4-Hydroxyindole

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C8H7NO
CAS Number:
2380-94-1
Molecular Weight:
133.15
Beilstein:
114905
EC Number:
219-177-2
MDL number:
MFCD00005667
UNSPSC Code:
12352100
PubChem Substance ID:
24853151
NACRES:
NA.22

Quality Level

200

Assay

99%

form

solid

mp

97-99 °C (lit.)

SMILES string

Oc1cccc2[nH]ccc12

InChI

1S/C8H7NO/c10-8-3-1-2-7-6(8)4-5-9-7/h1-5,9-10H

InChI key

NLMQHXUGJIAKTH-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

Glucouridination of 4-hydroxyindole by human uridine 5′-diphospho-glucuronosyltransferase has been repotrted.

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 3

1 of 3

4-Bromoindole 96%

Sigma-Aldrich

524336

4-Bromoindole

Psilocybin solution 1.0 mg/mL in acetonitrile: water (1:1), ampule of 1 mL, certified reference material, Cerilliant®

Supelco

P-097

Psilocybin solution

7-Methylindole 97%

Sigma-Aldrich

M51490

7-Methylindole

Marek Bednarski et al.
Archiv der Pharmazie, 349(3), 211-223 (2016-02-09)
β-Adrenergic receptor antagonists are important therapeutics for the treatment of cardiovascular disorders. In the group of β-blockers, much attention is being paid to the third-generation drugs that possess important ancillary properties besides inhibiting β-adrenoceptors. Vasodilating activity of these drugs is
Stefan W Toennes et al.
Journal of pharmaceutical and biomedical analysis, 140, 215-222 (2017-04-04)
Each year, synthetic cannabinoids are occurring in high numbers in the illicit drug market, but data on their pharmacology and toxicology are scarcely available. Therefore, a pilot study was performed to assess adverse effects of JWH-018, which is one of
Shalenie P den Braver-Sewradj et al.
Current drug metabolism, 19(4), 370-381 (2018-01-11)
Inter-individual variability in hepatic drug metabolizing enzyme (DME) activity is a major contributor to heterogeneity in drug clearance and safety. Accurate data on expression levels and activities of DMEs is an important prerequisite for in vitro-in vivo extrapolation and in
Alexandra M Adams et al.
Metabolic engineering, 56, 111-119 (2019-09-25)
Psilocybin, the prodrug of the psychoactive molecule psilocin, has demonstrated promising results in clinical trials for the treatment of addiction, depression, and post-traumatic stress disorder. The development of a psilocybin production platform in a highly engineerable microbe could lead to
Nenad Manevski et al.
Drug metabolism and disposition: the biological fate of chemicals, 38(3), 386-395 (2009-12-17)
We have examined the glucuronidation of psilocin, a hallucinogenic indole alkaloid, by the 19 recombinant human UDP-glucuronosyltransferases (UGTs) of subfamilies 1A, 2A, and 2B. The glucuronidation of 4-hydroxyindole, a related indole that lacks the N,N-dimethylaminoethyl side chain, was studied as
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service